Management of Biological Therapy Before Elective Inflammatory Bowel Disease Surgeries

Inflammatory Bowel Diseases
Tawnya M HansenYvette Leung

Abstract

Increasing uptake of biologic therapy has contributed to declining surgical rates for inflammatory bowel disease (IBD). However, a significant number of patients on biologic therapy will go on to require surgery. The literature is conflicted with regard to the preoperative management of biologic therapy before urgent or elective IBD surgery. This article reviews the available data on postoperative complications following preoperative treatment with anti-tumor necrosis factor alpha therapy, anti-integrin therapy, and anti-interleukin therapy.

References

Dec 1, 1978·The British Journal of Surgery·W N BakerS O Aylett
Nov 1, 1990·British Journal of Plastic Surgery·C W Martin, I F Muir
Mar 1, 1990·Diseases of the Colon and Rectum·C E LeijonmarckG Hellers
May 30, 1998·Journal of Gastroenterology·M ShinozakiT Muto
Sep 12, 1998·The Journal of Surgical Research·G O MaishR N Cooney
Feb 24, 2001·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·R H LeeA Barbul
Aug 9, 2003·Diseases of the Colon and Rectum·Roberto BergamaschiJean-Pierre Arnaud
Jan 8, 2004·JAMA : the Journal of the American Medical Association·Kane O PryorPeter A Goldstein
Sep 22, 2005·Diseases of the Colon and Rectum·David W LarsonTonia M Young-Fadok
May 8, 2007·Journal of the American College of Surgeons·Chelliah R SelvasekarJohn H Pemberton
Jul 12, 2008·The American Journal of Gastroenterology·Venkataraman SubramanianRichard C G Pollok
Aug 19, 2008·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Kweku A AppauRavi P Kiran
Aug 19, 2008·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Hiroko KunitakeLiliana Bordeianou
Sep 3, 2008·International Journal of Colorectal Disease·George E ReeseParis P Tekkis
May 26, 2010·Alimentary Pharmacology & Therapeutics·P ZerbibJ F Colombel
Sep 28, 2010·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Basil S NasirDavid W Larson
May 26, 2011·Gut·Guillaume Bouguen, Laurent Peyrin-Biroulet
Aug 13, 2011·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·Y LeeJ R T Monson
Sep 20, 2011·Inflammatory Bowel Diseases·Michael S KasparekMartin E Kreis
Nov 19, 2011·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Emi KannoMasahiro Tachi
Mar 13, 2012·Journal of Crohn's & Colitis·David BregnbakFlemming Bendtsen
Apr 20, 2012·Diseases of the Colon and Rectum·A TzivanakisB D George
May 23, 2012·The American Journal of Gastroenterology·Laura E TargownikCharles N Bernstein
Sep 5, 2012·The American Journal of Gastroenterology·Laurent Peyrin-BirouletEdward V Loftus
Jan 10, 2013·Annals of Surgery·Victor Warren FazioSean T Martin
Mar 26, 2013·Journal of Crohn's & Colitis·Vincent BillioudLaurent Peyrin-Biroulet
May 8, 2013·The British Journal of Surgery·T SerradoriL Bresler
May 24, 2013·JAMA Surgery·Caitlin W HicksLiliana Bordeianou
Jun 27, 2013·Annals of Surgery·Marie GrønkjærTrine Flensborg-Madsen
Aug 24, 2013·The New England Journal of Medicine·Brian G FeaganUNKNOWN GEMINI 1 Study Group

❮ Previous
Next ❯

Citations

May 12, 2021·World Journal of Emergency Surgery : WJES·Belinda De SimoneFausto Catena

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.